← Open Payments lookup

SUMER ANDERSON: Open Payments

NPI 1992071559 · SANDY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,061 in 97 payments from 20 companies in 2025. Trend: 2023 $1,609 · 2024 $2,236 · 2025 $2,061

Food & beverage: $2,061
CompanyPaymentsAmount
ABBVIE INC.16$308
Janssen Pharmaceuticals, Inc9$206
Neurocrine BioSciences, Inc.9$195
Alkermes, Inc.7$182
Vanda Pharmaceuticals Inc.6$176
Takeda Pharmaceuticals U.S.A., Inc.6$165
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$159
Otsuka America Pharmaceutical, Inc.7$148
Tris Pharma Inc5$106
Lundbeck LLC4$79

Products named: VRAYLAR, REXULTI, INGREZZA, ARISTADA, FANAPT, SPRAVATO, TRINTELLIX, CAPLYTA.

Industry payments across UT — which companies pay providers there.